105－108年度市售中藥材混誤用狀況分析   全文下載

Analysis of the Confusion and Misuse of Chinese Herbs in Taiwan Market, 2016-2019

中藥材品種繁多、外觀相近、各地用藥名稱及使用習慣不同等因素，而有混淆及誤用的可能。本調查於105至108年間，由各地方政府衛生局至轄區內抽查市售中藥材102品項（共計1,368件）進行藥材鑑定，並分別依誤用藥材、夾雜物過多及其他3大面向進行分析討論。調查結果顯示，102品項中藥材中有12品項發生藥材誤用，包括五加皮、黃耆、懷牛膝、茵陳、骨碎補、枳實、菟絲子、木通、桑寄生、白花蛇舌草、藿香及王不留行。其中以骨碎補、五加皮及藿香藥材誤用比例為最高；3品項有夾雜物過多情形，分別為柴胡、夏枯草及菟絲子，發生率均在75％以上。除此之外，有1件蛇床子因包裝內夾雜昆蟲、產品品質不佳，因與他種藥材狀況相異，故列入其他進行分析。本調查結果均逐案函復原送驗單位及衛生福利部中醫藥司，以確保國人用藥正確與安全。

The confusion and misuse of Traditional Chinese herbs may occur due to large variety of species, similar outward appearances, different names and usage custom in different regions. In order to investigate Chinese herbs' quality, a total of 1,368 samples (102 species) were collected from Chinese medicinal manufactory plants and drug stores in Taiwan by local health bureaus from 2016 to 2019. Analysis was done on three aspects including misuse of herbs, presence of excessive impurities and others. The survey found misuse in 12 species, while Drynariae Rhizoma, Acanthopanacis Cortex and Agastachis Herba had higher misuse rate. In addition, three species were found excessive impurities including Bupleuri Radix, Prunellae Spica and Cuscutae Semen, of which the proportions were above 75%. Furthermore, one sample has insects and its package was broken which was different from the above two aspects thus listed in the aspect of others. The results were replied to relevant authorities including local health bureaus, and the Department of Chinese Medicine and Pharmacy for further processing to protect public health and medication safety.